Cargando…
PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study
Programmed cell death receptor ligand-1 (PD-L1) expression, KRAS (KRASm) and EGFR (EGFRm) mutations may influence non-small cell lung cancer (NSCLC) prognosis. We aimed to evaluate PD-L1 expression, KRASm, and EGFRm and survival among stage III unresected NSCLC patients. Using Danish registries, we...
Autores principales: | Cronin-Fenton, Deirdre, Dalvi, Tapashi, Movva, Naimisha, Pedersen, Lars, Hansen, Hanh, Fryzek, Jon, Hedgeman, Elizabeth, Mellemgaard, Anders, Rasmussen, Torben R., Shire, Norah, Hamilton-Dutoit, Stephen, Nørgaard, Mette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377072/ https://www.ncbi.nlm.nih.gov/pubmed/34413420 http://dx.doi.org/10.1038/s41598-021-96486-2 |
Ejemplares similares
-
Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark
por: Dalvi, Tapashi, et al.
Publicado: (2023) -
Interferon gamma expression and mortality in unselected cohorts of urothelial bladder cancer patients
por: Gillezeau, Christina, et al.
Publicado: (2022) -
Validation of an Algorithm to Ascertain Late Breast Cancer Recurrence Using Danish Medical Registries
por: Pedersen, Rikke Nørgaard, et al.
Publicado: (2020) -
Comorbidity and survival of Danish breast cancer patients from 2000–2011: a population-based cohort study
por: Ording, Anne Gulbech, et al.
Publicado: (2013) -
Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age
por: Movva, Naimisha, et al.
Publicado: (2022)